FDA puts Novavax's phase 3 plan for pair of vaccine programs on hold over nerve disease case
Novavax’s plans for growth outside of its COVID program have been thrown into chaos after the FDA put the biooharma's flu programs on hold in response to a case of nerve disease from a former parti | The phase 2 trial wrapped up in July 2023,
An infant, and a 90+ year-old adult, were the first Connecticut residents to die from the flu in the 2024-25 season.
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Sanofi (SNYNF, SNY) said that the U.S. Food and Drug Administration has updated the label for FLUBLOK (Influenza Vaccine) to include ...
The Respiratory Surveillance Service has begun operating in Hungary as a first step in preparing for the flu season.
FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for ...
The U.S. Food and Drug Administration (FDA) has updated the label for FLUBLOK (Influenza Vaccine) to include data from a new safety study involving pregnant individuals 18 years and older, in time to ...
CSL Seqirus, a global vaccine maker with a massive manufacturing plant in Holly Springs, has received two federal grants ...
A recent study has evaluated the effectiveness of influenza vaccines in children aged 6–59 months in Spain during the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback